Cytokine-induced glucocorticoid secretion and glucocorticoid inhibition of cytokine synthesis and pleiotropic actions act as important safeguards in preventing cytokine overreaction. We found that TNF-␣ increased glucocorticoid-induced transcriptional activity of the glucocorticoid receptor (GR) via the glucocorticoid response elements (GRE) in L-929 mouse fibroblasts transfected with a glucocorticoid-inducible reporter plasmid. In addition, TNF-␣ also enhanced GR number. The TNF-␣ effect on transcriptional activity was absent in other cell lines that express TNF-␣ receptors but not GRs, and became manifest when a GR expression vector was cotransfected, indicating that TNF-␣ , independent of any effect it may have on GR number, has a stimulatory effect on the glucocorticoid-induced transcriptional activity of the GR. Moreover, TNF-␣ increased GR binding to 
Introduction
An important feature of immune or inflammatory responses is the marked increase in cytokine synthesis. These cytokines activate the hypothalamic-pituitary-adrenal system, causing an elevation of systemic glucocorticoid levels (1, 2) . Glucocorticoids inhibit both cytokine gene expression and pleiotropic actions on target cells, acting as immunosuppressive and antiinflammatory agents that contain overreactions of the immune system, as well as autoaggressive responses (3) (4) (5) (6) (7) .
There is evidence that endotoxin and/or inflammatory cytokines increase the number of glucocorticoid receptors (GR) 1 in murine macrophages (8) and human lymphoid, monocytoid, and hepatoma cell lines (9) . However, sensitivity to glucocorticoids may involve other mechanisms, since tissues with similar GR capacity show widely varying responsiveness to glucocorticoids (10, 11) . Noncytokine immune factors, such as immunophilins (12, 13) , have been shown to regulate glucocorticoidinduced GR-mediated gene transcription. Immune mediators may exert their regulatory effects through a cross talk at the level of specific nucleotide sequences present in genes whose transcription is modulated by glucocorticoids. Were this the case, then cytokines, in addition to inducing glucocorticoid secretion (1, 2) , might modulate the action of glucocorticoids at the target cell level, increasing the cell's sensitivity to the inhibitory effect of glucocorticoids after infection or inflammation.
To examine this possibility, we studied the effects of cytokines on the capacity and transcriptional activity of GR via the glucocorticoid response elements (GRE) in different target cell lines. In addition, we examined the consequences on the biological action of glucocorticoids on these cells.
Methods
Cells and reagents. The cell lines L-929 (mouse fibroblasts), AtT-20 (mouse anterior pituitary cells), U-373 (human glioblastoma), HeLa (human epithelioid carcinoma cells), CV1 (monkey kidney cells), and SK-N-MC (human neuroblastoma) were grown in DME (Gibco Laboratories, Grand Island, NY) supplemented with 10% charcoalstripped steroid-free FCS (Gibco, Paisley, United Kingdom), penicillin (100 U/ml), and streptomycin (100 g/ml). The cells were maintained at 37 Њ C in a humidified atmosphere of 5% CO 2 . Unless stated, reagents were from Sigma Chemical Co. (St. Louis, MO), Boehringer (Mannheim, Germany), or Pharmacia (Uppsala, Sweden).
Construction of reporter and expression plasmids. The construction of the reporter plasmids MTV-CAT, MTV-LUC, and ⌬ MTV-CAT have been described previously (14) . Briefly, the MTV-CAT is a glucocorticoid-inducible reporter plasmid containing the complete mouse mammary tumor virus-long terminal repeat (MTV-LTR) promoter upstream of the gene for chloramphenicol acetyltransferase (CAT), while the MTV-LUC contains luciferase (LUC) as reporter gene. The ⌬ MTV-CAT plasmid contains a modified MTV-LTR sequence upstream of the CAT reporter gene in which bases Ϫ 190 to Ϫ 88 have been deleted, thus eliminating three out of the four consensus GRE known to reside within the MTV-LTR (15) .
The plasmid pRShGR ␣ , described previously (16) , is an expression vector for the GR under the control of the RSV promoter.
The plasmid pCH110 (Pharmacia, Freiburg, Germany) contains a functional lac Z gene, coding for ␤ -galactosidase, under the transcriptional control of the SV40 early promoter.
Transfections and assays of CAT, LUC, and ␤ -galactosidase activities. L-929, U-373, HeLa, and AtT-20 cell lines were transfected by calcium phosphate coprecipitation, according to the described method (17) . Briefly, cells were cultured in plates of 10 cm at 80% of confluence in DME with 10% charcoal-stripped steroid-free FCS. Medium was removed and 1 ml of the transfection buffer (HepesCaCl 2 ) containing 20 g of MTV-CAT plasmid was added. After 20 min, 9 ml of culture medium was added and plates were incubated at 37 Њ C and 5% of CO 2 for 4 h. Cells were then shocked with Hepesglycerol 15%, 3 min, washed twice with PBS, and incubated with DME with 10% charcoal-stripped FCS in the presence of TNF-␣ (R & D Systems, Minneapolis, MN), IL-1 ␤ , or dexamethasone (DEX) during 24 h. Cellular extracts for CAT assay were made by freezethaw lysis and CAT assay was performed as described (18) . CV1 and SK-N-MC cell lines were transfected by the electroporation method as described (19, 20) . Briefly, cells were seeded at high density 5 x 10 4 / cm 2 in DME with 10% charcoal-stripped steroid-free FCS. Cells were then allowed to grow to 75% confluence. Transfection was carried out using an electroporation system (Biotechnologies and Experimental Research Inc., San Diego, CA). 5 g of the reporter plasmid MTV-LUC and in some cases 5 g of the GR expression vector pRShGR ␣ were cotransfected. Electroporated cells were replated in DME supplemented with 10% steroid-free FCS and incubated immediately with glucocorticoids and TNF-␣ . After 24 h, cells were harvested and extracts were assayed for LUC activity (21) .
For all cells, 5 g of pCH110 was cotransfected and ␤ -galactosidase activity was measured (22) in order to correct for variations in transfection efficiency.
Determination of p55 TNF-␣ receptor mRNA. Northern blot was performed as described previously (23) . Briefly, total RNA, isolated by the guanidine isothiocyanate phenol-chloroform extraction method, was denatured with glyoxal, electrophoresed on a 1.2% agarose gel, and transferred overnight to a nylon membrane. Filters were baked for 2 h at 80 Њ C and stained with methylene blue. They were prehybridized for 4 h at 60 Њ C (50% formamide, 5 ϫ SSPE, 5 ϫ Denhardt's solution, 0.1% SDS, 100 g/ml denatured salmon sperm DNA) and then the probe was added for 12 h. Blots were washed at increasing salt and temperature stringency with a final wash of 30 min at 60 Њ C in 0.1 ϫ SSC containing 0.1% SDS. Dried filters were exposed to Kodak XAR5 film at Ϫ 70 Њ C with intensifying screens for 2 d. The p55 TNF-␣ receptor (PstI-BamHI 0.738 kb) and 1 kb PstI actin cDNA probes (specific activity, 2-4 ϫ 10 8 cpm/ g) were labeled with a randompriming kit using [ ␣ - Electrophoretic mobility shift assay (EMSA). EMSA was performed as described previously (19) . Briefly, after 15, 45, 60, or 120 min of stimulation, L-929 cells were collected, washed with PBS, and nuclear protein extracted as follows. Cells were lysed in 100 l of buffer A (10 mM Hepes, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, and 0.1% NP-40). After centrifugation, the nuclear pellet was lysed with 20 l of buffer B (20 mM Hepes, 1.5 mM MgCl 2 , 0.42 mM NaCl, 0.5 mM DTT, 0.5 mM PMSF, 25% glycerol, and 0.2 mM EDTA). The subsequent soluble fraction was mixed with 100 l of buffer C (10 mM Tris-HCl, pH 7.5, 80 mM KCl, 10% glycerol, and 1 mM DTT). Double-stranded oligonucleotides encoding the GRE (5 Ј AGC-TTCGTAGCTAGAACATCATGTTCTGG-3 Ј ) (19) and the NF B binding site (5 Ј TCGAAATGTGGGATTTTCCCATGAGT-3 Ј ) were end-labeled incorporating [ ␣ - 32 P]CTP and filling in the recessed ends using Klenow fragment (Boehringer). The unrelated double-stranded oligonucleotide CCAAT (5 Ј GATCCCGGAGCCCGGGCCAATCGG-CGCA-3 Ј ) was end-labeled using [ ␥ -32 P]ATP and T 4 polynucleotide kinase. Equal amounts (10-16 g) of each sample or RelA (a generous gift from Dr. H. Martinetto, INGEBI, Argentina) were incubated in a total volume of 20 l of buffer containing 600 ng or 1 g of poly (dI-dC) и (dI-dC). A 50-100-fold excess of unlabeled GRE, NF B binding site, or nonspecific competitor oligomer CCAAT was included in the reaction where indicated. After incubation on ice for 10 min, end-labeled oligonucleotides (17,000 cpm) were added and the incubation was continued for 20 min at 25 Њ C. DNA-protein complexes were resolved on a 4% nondenaturing polyacrylamide gel with buffer recirculation in 6.7 mM Tris-HCl (pH 7.5), 3.3 mM sodium acetate, 1 mM EDTA. The gels were dried under vacuum and autoradiographed at Ϫ 70 Њ C.
Cytotoxicity assay. Cytotoxicity was performed as described (24) . Briefly, L-929 cells were plated at 3 ϫ 10 5 cells/well in 96-well microtiter plates in the presence of different doses of TNF-␣ and DEX for 24 h. For the priming experiments, TNF-␣ 0.02 ng/ml was added before for 12 h. Plates were stained with 0.5% gentian violet in 70% methanol and were then washed and resuspended in acetic 33% solution; the absorbance was determined at 570 nm.
Apoptosis. L-929 cells were seeded in chamber slides at a density of 4 ϫ 10 5 cells/ml, with TNF-␣ 60 ng/ml and DEX 10 or 100 nM for 8 h, and apoptosis was determined by the terminal transferase-mediated dUTP-biotin nick end labeling method (TUNEL) (25) . Briefly, after incubation, cells were washed three times with ice-cold PBS and fixed with 2% paraformaldehyde in PBS (30 min, room temperature). They were then washed once, permeabilized by incubating (2 min, 4 Њ C) with 0.1% Triton/0.1% sodium citrate and then washed twice with PBS. The TUNEL reaction was carried out by incubating the cells in a moist chamber (1 h, 37 Њ C) with 0.5 nmol biotin-16-dUTP, 3 nmol dATP, 2 l 25 mM CoCl 2 , 25 U terminal transferase (TdT) (Boehringer) and TdT buffer (25 mM Tris-HCl, pH 7.2, 200 mM potassium cacodylate) in a total reaction volume of 50 l for each condition. The reaction was stopped by adding 2 l 0.5 M EDTA. Cells were washed and incubated with a 1:500 dilution of rhodamine-conjugated streptavidin (Dianova, Hamburg, Germany) for 45 min. After washing three times, cells were analyzed for fluorescence in an Olympus IMT-2 microscope. DNase treatment was used as positive control. The number of apoptotic cells was determined by counting at least 10 different fields for each sample.
GR measurement. L-929 cells were processed as described previously (26) . The cells were collected by centrifugation and the pellet was homogenized (two pellets, 2 ϫ 10 7 cells/2 ml; 10 strokes at 900 rpm) in ice-cold 5 mM Tris-HCl (pH 7.4) containing 0.5 mM phenylmethylsulfonyl fluoride, 5 g/ml antipain, 5 g/ml leupeptin, 5% glycerol, 10 mM sodium molybdate, 1 mM EDTA, and 2 mM ␤ -mercaptoethanol. The homogenate was centrifuged at 100,000 g for 60 min at 0-2 Њ C to obtain cytosol (i.e., supernatant fraction). Aliquots of cytosol (100 l) were incubated with 3 H-labeled steroids over a concentration range of 0.5-10 nM (seven concentrations; total volume 150 l). Total binding to soluble macromolecules was determined with 3 H-DEX (85-106 Ci/mmol; Amersham, Braunschweig, Germany). Nonspecific binding was determined in parallel incubations containing a 1,000-fold excess of DEX in addition to cytosol and 3 H-DEX. After incubation for 20-24 h at 0 Њ C, bound and free 3 H-DEX were separated by Sephadex LH-20 (Pharmacia, Sweden) gel filtration and radioactivity was measured in a liquid scintillation counter. The protein concentration was determined by the method of Lowry (27) with BSA as the standard. Nonspecific binding was subtracted from total binding to yield specific binding. Binding data were expressed as fem-tomoles per milligram of protein (fmol/mg) and the maximal number of binding sites (B max ) and relative binding affinity ( K d ) were determined by nonlinear regression analysis.
Statistics. Statistics were performed using one-way ANOVA in combination with Scheffé's test. Results are expressed as meanϮSEM.
Results

TNF-␣ increases GR number and glucocorticoid-induced transcriptional activity.
In mouse L-929 fibroblasts (TNF-␣ target cells that express GRs) transiently transfected with the plasmid MTV-CAT, noncytotoxic doses of TNF-␣ increased glucocorticoid-induced CAT activity (Fig. 1) . This enhancement was blocked by addition of RU 38486, which antagonizes the GR (Fig. 1) , and was absent in cells transfected with a vector lacking GREs (Fig. 1, inset) , indicating that the effect on CAT activity is exerted via the GREs. TNF-␣ itself had no effect on CAT activity (not shown).
TNF-␣ also led to an increase in GR number in L-929 cells but did not alter receptor affinity (Fig. 2) .
Transfection with the MTV-LUC plasmid in two cell lines that express TNF-␣ receptors (Fig. 3 A, inset) but not GRs (CV1 monkey kidney cells and SK-N-MC human neuroblastoma) did not lead to any reporter gene activity in response to either glucocorticoid on its own or combined with TNF-␣ (Fig.  3 A) . However, TNF-␣ enhancement of glucocorticoid-induced transcriptional activity was present when both cell lines were cotransfected with MTV-LUC and an expression vector for the GR under the RSV promoter (Fig. 3 B) . TNF-␣ did not alter LUC expression of the construct RSV-LUC, which contains the promoter (RSV) from the GR expression vector (not shown). This indicates that TNF-␣, independent of any effect it may have on GR number, has a stimulatory effect on the glucocorticoid-induced transcriptional activity of the GR via the GRE. This action is more pronounced in target cells that express these receptors naturally, because TNF-␣ also leads to an increase in GR number.
TNF-␣ increased the DEX-induced binding of the GR to the GRE, as shown by EMSA, even at time points (e.g., 15 min) at which an effect of an increase in GR number is most probably negligible (28) (Fig. 4 A, lanes 4 and 5 and Fig. 4 B,  lanes 1 and 2) . The specificity for GRE binding of the electrophoretic mobility shift complexes obtained with DEX and TNF-␣ was demonstrated using unlabeled oligomers in competition experiments. A 50-100-fold excess of unlabeled GRE competed efficiently for receptor binding (Fig. 4 A, lanes 3 and  6 and Fig. 4 B, lane 4) in contrast to the same excess of an unrelated oligomer (Fig. 4 A, lanes 1 and 2 and Fig. 4 B, lane 3) . When an oligonucleotide encoding the CCAAT site of the fibronectin gene was used as control probe, no differences in the Cells were cotransfected and stimulated with cortisol (3 nM) and TNF-␣ (0.02 ng/ml) for 24 h. The diagram bar corresponds to the meanϮSEM of arbitrary units of LUC activity corrected for transfection efficiency by the corresponding ␤-galactosidase activity of four independent experiments for each cell line, in which each condition was performed in triplicate. TNF-␣ itself had no effect on the LUC activity.
was included in the reaction mixtures. The assay was performed using 1 g of poly (dI-dC)и(dI-dC) in the reaction buffer. Densitometric ratio: DEX plus TNF-␣ (lane 5)/DEX (lane 4): 1.82 (relative to binding obtained with the same amount of extracts in C). TNF-␣ itself had no effect. Similar results were obtained in three independent experiments in which nuclear extracts were obtained after 15, 45, or 60 min of cell stimulation. (B) EMSA and competition assays were performed using labeled GRE oligomer and 10 g of nuclear proteins from L-929 cells (lanes 1-4) , which were stimulated as in A. 600 ng of poly (dI-dC)и(dI-dC) was used in the incubation buffer. Densitometric ratio: DEX plus TNF-␣ (lane 2)/DEX (lane 1): 1.38 (relative to binding obtained with the same amount of extracts with the oligonucleotide CCAAT). Similar results were obtained in two additional independent experiments. (C) The EMSA was performed using the same amount (16 g) of the same nuclear extracts used in A and labeled oligonucleotide CCAAT (corresponding to other DNA-protein complexes not related to GR/GRE), confirming that they contain the same amount of proteins. The assay was performed using 1 g of poly (dI-dC)и(dI-dC) in the reaction buffer. Similar results were obtained with all the extracts used in A and B. 1-6) , which were stimulated for 45 min with 10 nM DEX (lanes 1-4) or DEX plus 0.02 ng/ml TNF-␣ (lanes 5 and 6) . For competition reactions, an excess of either unlabeled GRE oligonucleotide (lanes 3 and 6) or a nonspecific competitor oligomer (lanes 1 and 2) intensities (corresponding to other DNA-protein complexes not related to GR/GRE) were detected between TNF-␣ plus DEX and DEX treated cells (Fig. 4 C, lanes 1 and 2) . This confirms that equal amounts of protein are compared in Fig. 4, A and B, and that the enhancement induced by TNF-␣ is specific for the GRE oligomer. No shift or extra bands were observed with TNF-␣ in the mobility of the GR/GRE complex, indicating that the TNF-␣ treatment does not induce any new protein that interacts directly with this complex (Fig. 4 A, lane 5 and Fig. 4 B, lane 2) . Compatible with the results obtained in the transfection experiments using a vector lacking GREs (Fig. 1,  inset) , the TNF-␣-induced enhancement of the GR/GRE binding observed when using a GRE oligomer, indicates that this effect does not necessarily require other DNA sequences.
At these same time points, and even up to 120 min after stimulation, DEX did not alter the NFB binding induced by TNF-␣ in L-929 cells (Fig. 5) .
TNF-␣ increases the sensitivity to glucocorticoid action. These changes had marked implications for the biological action of TNF-␣ and glucocorticoids on L-929 cells. The cytotoxicity/ apoptosis induced by TNF-␣ in L-929 cells was shown to be inhibited by glucocorticoids (29) (30) (31) . We used human TNF-␣ that binds only to the mouse p55 receptor subtype that belongs to the family of receptors, such as FAS/APO1, that mediate apoptosis (32, 33) , particularly in L-929 fibroblasts (34) , and measured both apoptosis and cytotoxicity, with and without TNF-␣ priming.
As shown previously by flow cytometric analysis (30) , DEX reduced the number of apoptotic cells (TNF-␣ 60 ng/ml ϭ 264Ϯ75 from total ϭ 450 cells, TNF-␣ 60 ng/ml ϩ DEX 10 nM ϭ 57Ϯ12 from total ϭ 300 cells) established by the TUNEL method, confirming that glucocorticoids effectively interfere with the cell death program induced by TNF-␣. As a functional biological correlate of the enhanced GR number and activity on the GRE-dependent transcriptional activity on L-929 cells, preincubation with a low noncytotoxic dose of TNF-␣ increased the sensitivity of TNF-␣-induced cytotoxicity to DEX inhibition (Fig. 6) . Priming with TNF-␣ thus increases the efficacy of glucocorticoids in blocking TNF-␣-induced cell death.
Enhancement of glucocorticoid-induced transcriptional activity by cytokines in different cell lines.
To establish the generality of this phenomenon, a number of other cell lines derived from different tissues which also express GR and cytokine receptors were transfected with the MTV-CAT construct. In U-373 human glioblastoma cells treated with TNF-␣ or IL-1␤ plus DEX (Fig. 7  A) , HeLa human epithelioid carcinoma cells after TNF-␣ plus DEX incubation (Fig. 7 B) and AtT-20 mouse anterior pituitary cells after IL-1␤ and DEX stimulation (Fig. 7 C) , combined DEX and cytokine stimulation, led to an increase in CAT activity compared with DEX action without cytokine treatment. These results show that the phenomenon is not limited to a single type of target cell or cytokine, and may thus reflect a general molecular mechanism whereby cytokines modulate the transcriptional activity of GRs.
Discussion
The interaction between nuclear receptors and the transcriptional activator AP-1 represents a major form of cross talk between two central signal transduction pathways, one used by ste- Figure 5 . Effect of glucocorticoids on TNF-␣-induced NFB binding. EMSA and competition reactions were performed using labeled NFB binding oligomer and 16 g of nuclear extracts from L-929 cells (lanes 1-3) , which were stimulated for 45 min with 0.02 ng/ml TNF-␣ (lane 1) or TNF-␣ plus 10 nM DEX (lanes 2 and  3) . For competition reactions, an excess of unlabeled NFB binding oligomer (B) (lane 3) was included in the reaction mixture. RelA was used as positive control (lane 4). The assay was performed using 1 g of poly (dI-dC)и(dI-dC) in the reaction buffer. Similar results were obtained in three independent experiments in which nuclear extracts were obtained at the indicated time and also at 15, 60, and 120 min. roid and thyroid hormones, as well as by retinoids, and the other by growth factors and cytokines (35) (36) (37) (38) (39) . This interaction leads to transcriptional interference and inhibition of the expression of AP-1 regulated genes, such as cytokines (35) (36) (37) (38) (39) . There is also a complex cross talk between NFB and GR, discussed below (40-44).
The enhancement of GR transactivation via GRE requires the presence of GR, glucocorticoid hormone, and cytokine in order to occur. This phenomenon can be accounted for in part by an increase in GR number, as shown in Fig. 2 . However, it also takes place when cells that do not express GRs are cotransfected with an expression vector for the GR, indicating that other mechanisms, such as increased GR binding to GRE and/or direct interaction of other transcription factors, must also exist. As shown in the EMSA studies, TNF-␣ increases the DEX-induced binding of the GR to the GRE and does not induce additional transcription factors that interact directly with the GR/GRE complexes. The TNF-␣ facilitation of the interaction of GR with its binding sites may involve an increase in the nuclear translocation of the GR and/or enhanced accessibility of the GR (i.e., changes in phosphorylation or conformation). We demonstrate, for the first time, that the regulatory loop whereby cytokine transduction signals cross talk with the GR may result in an enhancement of the transcriptional activity of these nuclear hormone receptors. In genes containing DNA sequences which are targets for different transcription factors, further interactions with the GR/ GRE may also occur. Cross-coupling of distinct pathways in certain situations may repress gene transcription but in others may activate gene expression.
There is a complex functional interaction between the GR and NFB. Two different mechanisms have been postulated: (a) a direct physical association of GR and RelA, the 65-kD NFB binding protein (40) (41) (42) ; and (b) the inhibition of NFB without physical association, through the induction by glucocorticoids of the synthesis of the inhibitor IB (43, 44) . With regards to NFB activity induced specifically by TNF-␣, it has been demonstrated that: (a) DEX inhibits this activation in EMSA studies with nuclear extracts obtained in cells pretreated for 5, 12, or 20 h with DEX (41,43); and (b) NFB released from IB after TNF-␣ induction quickly reassociates with newly synthesized IB in the presence of DEX, thus markedly reducing the amount of NFB that translocates to the nucleus (43, 44) . In our experiments, as a net result of all the mechanisms involved (the balance of the putative formation of NFB/GR complexes and the increase in the synthesis of IB sequestrating NFB, and the enhancement of GR binding of GRE), DEX does not change the NFB activity induced by TNF-␣, at the same time points at which TNF-␣ enhances the binding of GR to GRE. Although the NF-B/GR complexes may downtitrate the activation of GRE induced by TNF-␣ (as shown in other cells in which cotransfection with an expression vector for RelA inhibits GRE reporter plasmids [40] [41] [42] ), our EMSA and transfection experiments show that the net result of TNF-␣ stimulation with regards to GRE is an enhancement of the GR transactivation via GRE. Furthermore, the enhancement of GR number by TNF-␣ will contribute to the dampening of TNF-␣ biological action by two independent but concomitant pathways, the inhibition of NFB activation (by the formation of NFB/GR complexes and/or the augmentation of IB) (40) (41) (42) (43) (44) and the enhancement of GRE responsive genes.
TNF-␣ is a pleiotropic cytokine, capable of killing mammalian cells in vitro and in vivo through a number of cellular effects, including cytotoxicity/apoptosis (32) (33) (34) (45) (46) (47) . The shock and tissue injury that occur in response to bacterial endotoxin is largely mediated by IL-1 and TNF-␣, which can also mediate cellular injury on normal tissues (6, 47-51). The re- (19) and stimulated for 24 h with DEX (10 nM), DEX plus IL-1␤ 100 IU/ml, or DEX plus TNF 0.02 ng/ml. The diagram bars correspond to the meanϮSEM of the densitometric analysis of CAT assay, standardized by the corresponding ␤-galactosidase, of three independent experiments for each cell line, in which each condition was performed in duplicate. TNF-␣ or IL-1␤ alone had no effect on CAT activity. duction of side effects of these cytokines is a major goal in the successful clinical management of endotoxemia. This may be achieved by desensitizing the target cells to their lethal effects. A state of hyporesponsiveness to endotoxin reactions (known as endotoxin tolerance) is induced in animals by prior administration of small amounts of endotoxin (52) (53) (54) . Glucocorticoids are directly involved in endotoxin tolerance, since adrenalectomized animals do not become endotoxin tolerant and tolerance can be restored by DEX administration (54) . Adrenalectomy is known to increase sensitivity to the lethal effects of TNF-␣ in mice (54) (55) (56) , and the same dose of anti-TNF-␣ that blocks its lethality in normal mice is ineffective in adrenalectomized animals (54) . Adrenalectomized animals that receive oral DEX 20 h before endotoxin injection produce significant amounts of TNF-␣ but become tolerant (i.e., show a survival rate similar to that of normal mice) (54) . The underlying mechanism remains unknown. However, based on our results, it is likely that the observed increase in tolerance is due to the increased sensitivity, induced by TNF-␣, of the target cells to the remaining low glucocorticoid concentration. Thus, cytokine enhancement of the negative control of their own biological action provides a new tool with which to lower cytokine lethal effects on target cells. Treatments that can increase the apoptotic thresholds of specific cells may be beneficial in the treatment of disorders associated with cell loss. After cytokine priming, GR-responsive genes present in target cells for cytokines will become more sensitive to regulation by glucocorticoids, as does the program of gene expression involved in the cell death induced by TNF-␣.
As mentioned above, cytokine-induced glucocorticoid secretion acts as an important safeguard in preventing cytokine deleterious effects, since glucocorticoids in turn inhibit cytokine synthesis (1-7). We now provide evidence for a cellular and molecular level of regulation between cytokines and glucocorticoids at the level of their target cells, the end result of which is to inhibit the biological action of cytokines. One of the physiologically critical functions of glucocorticoids is to prevent the immune system from overreacting (57) . By both inducing glucocorticoid production and enhancing their inhibitory action on target cells, cytokines contribute to the control of this overshooting.
